Scope
The IAP–NNF chapter treats neonatal pain assessment as routine care and combines developmentally appropriate comfort measures with analgesia when indicated. It distinguishes analgesia from sedation, recommends premedication for nonemergency intubation, and avoids routine opioid infusions for all ventilated newborns. This summary covers assessment, treatment selection, monitoring and parent education; inconsistent scoring and tapering details are excluded from bedside calculation or prescribing rules.
Written by House with AI assistance · AI-assisted source check 29 October 2026.
This is House’s summary of the cited guidance. The source check is not an independent clinician review. Open the publication for complete recommendations, exceptions, evidence grades and later amendments.
Score pain and document response
- Assess and document pain with every set of vital signs, using a validated scale appropriate to the clinical setting. Reassess within 30 minutes after an analgesic dose and record the response. [1]
- The chapter uses PIPP-R for preterm procedural pain, N-PASS for pain and sedation across neonatal intensive care, and COMFORT-Neo for prolonged or ventilated pain. These tools serve different contexts and are not interchangeable unstructured impressions. [1]
- Add pharmacological analgesia for severe procedures or when the validated score indicates substantial pain. The chapter’s explicit triggers are PIPP-R above 12 or N-PASS above +7. Record baseline score, drug, dose, route, time and the postdose assessment. [1]
Combine comfort measures with necessary analgesia
- Use nonpharmacological measures first for painful procedures at every gestation, and combine them with medicines for moderate-to-severe pain. Options include skin-to-skin contact, non-nutritive sucking, facilitated tucking and appropriately selected feeding or oral sweet solution. [1]
- For stable babies, skin-to-skin care can begin 15–30 minutes before the procedure and continue throughout. Non-nutritive sucking can be combined with sucrose; facilitated tucking keeps the limbs flexed toward the midline. [1]
- Use oral sucrose on the tongue or orally, not through a nasogastric tube, because intragastric administration does not provide the intended analgesic effect. Dextrose is an alternative when sucrose is unavailable. [1]
- Combine strategies and reduce environmental stimulation through dimmed lights, clustered care and less handling. Parents can contribute skin-to-skin care, gentle touch and other appropriate comfort measures. [1]
Select medication for the procedure and infant
- Fentanyl is the preferred opioid for acute procedural pain. Morphine can be used for ongoing pain in ventilated babies at or beyond 28 weeks, but routine opioid infusions for every ventilated neonate are not recommended; use documented score-based indications. [1]
- Avoid morphine below 28 weeks and in hypotension, acute kidney injury or poor gastrointestinal motility, as stated in the drug table. Opioid administration requires continuous cardiorespiratory monitoring and readiness to manage adverse effects. [1]
- Midazolam provides sedation, not analgesia, and must not be the sole treatment for pain. Never give a muscle relaxant without prior analgesia and trained staff. [1]
- Use analgesic premedication for nonemergency intubation. The chapter describes fentanyl with atropine and optional vecuronium; a muscle relaxant requires an experienced intubator and prior analgesia. [1]
- For a planned procedure, topical anaesthesia may be appropriate, but EMLA has delayed onset and should not be used as the solution for an urgent procedure. The chapter advises avoiding EMLA below 37 weeks or with methaemoglobinaemia risk. [1]
- Dexmedetomidine remains an emerging option with limited neonatal evidence in this chapter. It supplies no routine dose recommendation and limits use to a research protocol or specialist consultation. [1]
Monitor closely and plan follow-up
- During a continuous opioid infusion, assess pain and sedation every 1–2 hours and document dose and response. Monitor breathing, oxygen saturation, blood pressure, heart rate and gastrointestinal tolerance. [1]
- Reassess a fentanyl infusion daily and wean at the earliest appropriate opportunity. During tapering, document a modified Finnegan assessment every 4 hours; this summary does not supply a percentage-based taper schedule. [1]
- If discharge includes an oral opioid taper, provide written dosing and taper instructions with early follow-up within 5–7 days. Teach parents to seek review for excessive crying, poor feeding, jitteriness, poor weight gain or inconsolability, and give written guidance on inadequate pain control or withdrawal. [1]
Limitations and use
- The quick scoring tables omit or conflict on some gestational-age adjustments; they are not reproduced as calculator algorithms. Use the validated instrument itself for scoring.
- The opioid taper table gives inconsistent interval and daily percentage descriptions. This summary does not provide a taper regimen, intravenous-to-oral conversion formula, or intubation-premedication dose chart.
- Procedure-specific and general drug tables differ in some doses and local-anaesthetic concentrations. The summary therefore covers treatment selection and monitoring without supplying a complete drug-dosing protocol.
This summary is selective and does not reproduce every recommendation. Apply the source’s population, setting and eligibility criteria, together with clinical judgement and local policy.
Summary sources
- Neonatal Pain Management
Selected recommendation material consulted
Publication details
- Issuing organisation
- IAP / NNF
- Resource type
- Quick-reference guideline · House clinical summary
- Source setting
- India
The source check confirms publication details and the linked edition. It does not certify every recommendation or its suitability for an individual patient. Publisher access conditions may apply.